ECSP20044931A - Una composición de pienso para la prevención o el tratamiento de la enfermedad de la necrosis hepatopancreática aguda ahpnd o el síndrome de las manchas blancas wss, que como componentes activos comprende una cepa de bacillus subtilis una cepa de bacillus pumilus y una cepa de bacillus licheniformis - Google Patents
Una composición de pienso para la prevención o el tratamiento de la enfermedad de la necrosis hepatopancreática aguda ahpnd o el síndrome de las manchas blancas wss, que como componentes activos comprende una cepa de bacillus subtilis una cepa de bacillus pumilus y una cepa de bacillus licheniformisInfo
- Publication number
- ECSP20044931A ECSP20044931A ECSENADI202044931A ECDI202044931A ECSP20044931A EC SP20044931 A ECSP20044931 A EC SP20044931A EC SENADI202044931 A ECSENADI202044931 A EC SENADI202044931A EC DI202044931 A ECDI202044931 A EC DI202044931A EC SP20044931 A ECSP20044931 A EC SP20044931A
- Authority
- EC
- Ecuador
- Prior art keywords
- strain
- bacillus
- ahpnd
- wss
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La presente divulgación se refiere a una composición de pienso para la prevención o el tratamiento de la enfermedad de la necrosis hepatopancreática aguda (AHPND) o el síndrome de las manchas blancas (WSS), que como un componente activo, comprende una cepa de Bacillus subtilis (KCCM11143P), una cepa de Bacillus pumilus (KCCM11144P) y una cepa de Bacillus licheniformis (KCCM11143P); medios de cultivo de las mismas; concentrados de las mismas; o materias secas de las mismas. La composición de pienso exhibe actividad antibacteriana contra Vibrio parahaemolyticus, que provoca AHPND en camarones y actividad antivírica contra el virus del síndrome de las manchas blancas (WSSV) que provoca el WSS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170184265 | 2017-12-29 | ||
KR1020180171280A KR102277987B1 (ko) | 2017-12-29 | 2018-12-27 | 바실러스 서브틸리스 균주, 바실러스 푸밀러스 균주 및 바실러스 리체니포미스 균주를 유효성분으로 포함하는 급성 췌장염 괴사증 (ahpnd) 또는 흰반점 증후군(wss)의 예방 또는 치료용 사료 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP20044931A true ECSP20044931A (es) | 2020-11-30 |
Family
ID=67261354
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSENADI202044912A ECSP20044912A (es) | 2017-12-29 | 2020-07-29 | Una composición de pienso para la prevención o el tratamiento de la enfermedad de la necrosis hepatopancreática aguda (ahpnd) o el síndrome de las manchas blancas (wss), que comprende una cepa de bacillus subtilis como un principio activo |
ECSENADI202044931A ECSP20044931A (es) | 2017-12-29 | 2020-07-29 | Una composición de pienso para la prevención o el tratamiento de la enfermedad de la necrosis hepatopancreática aguda ahpnd o el síndrome de las manchas blancas wss, que como componentes activos comprende una cepa de bacillus subtilis una cepa de bacillus pumilus y una cepa de bacillus licheniformis |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSENADI202044912A ECSP20044912A (es) | 2017-12-29 | 2020-07-29 | Una composición de pienso para la prevención o el tratamiento de la enfermedad de la necrosis hepatopancreática aguda (ahpnd) o el síndrome de las manchas blancas (wss), que comprende una cepa de bacillus subtilis como un principio activo |
Country Status (13)
Country | Link |
---|---|
US (2) | US20200315211A1 (es) |
EP (2) | EP3530123A4 (es) |
JP (3) | JP6898989B2 (es) |
KR (2) | KR20190082122A (es) |
CN (2) | CN110602950A (es) |
AR (2) | AR113725A1 (es) |
AU (2) | AU2018395021A1 (es) |
BR (2) | BR112019007616B1 (es) |
CL (3) | CL2019001464A1 (es) |
CO (2) | CO2020009486A2 (es) |
EC (2) | ECSP20044912A (es) |
PH (2) | PH12019500838A1 (es) |
TW (2) | TWI722358B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190082122A (ko) * | 2017-12-29 | 2019-07-09 | 씨제이제일제당 (주) | 바실러스 서브틸리스 균주를 유효성분으로 포함하는 급성 췌장염 괴사증 (ahpnd) 또는 흰반점 증후군(wss)의 예방 또는 치료용 사료 조성물 |
KR102154172B1 (ko) * | 2019-03-28 | 2020-09-10 | 전한택 | 흰반점증후군바이러스 및 비브리오 세균의 갑각류 감염을 억제하는 생균제 및 그의 용도 |
KR102255611B1 (ko) | 2019-10-14 | 2021-05-24 | 염상구 | 복합 균주를 이용한 완전배합 발효사료의 제조방법 |
CN111165652A (zh) * | 2020-01-19 | 2020-05-19 | 博益德(北京)生物科技有限公司 | 一种河蟹用发酵饲料及其制备方法与应用 |
CN112753629B (zh) * | 2020-12-30 | 2022-08-30 | 亚太海洋生物科技(厦门)有限公司 | 南美白对虾养殖前期去除急性肝胰腺坏死病毒的方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100824106B1 (ko) * | 2006-05-30 | 2008-04-21 | 주식회사 씨티씨바이오 | 흰반점바이러스를 치료 또는 예방하기 위한 조성물 및 방법 |
KR20080061582A (ko) * | 2006-12-28 | 2008-07-03 | 부경대학교 산학협력단 | 흰반점 바이러스 항원 유전자의 재조합 단백질 생성 및발현방법과 이를 이용한 면역증강 사료첨가제 |
KR100977407B1 (ko) | 2008-02-26 | 2010-08-24 | 대한민국 | 비특이 면역증강 효능이 있는 자이고사카로마이세스 바일리용균추출물 |
KR20110035554A (ko) | 2009-09-30 | 2011-04-06 | 전남대학교산학협력단 | 바실러스 속 cmb l1 및 락토바실러스 속 cmb 201의 혼합균주 및 이를 이용한 항암 및 면역증강용 식품 조성물 |
KR101242821B1 (ko) | 2011-01-31 | 2013-03-12 | 씨제이제일제당 (주) | 비브리오 속 미생물에 대한 생물학적 방제용 프로바이오틱스 |
KR101230813B1 (ko) * | 2011-01-31 | 2013-02-06 | 씨제이제일제당 (주) | 사프로레그니아 속 미생물에 대한 생물학적 방제용 프로바이오틱스 |
KR20130047329A (ko) * | 2011-10-31 | 2013-05-08 | 대한뉴팜(주) | 바실러스 서브틸리스 np15 균주를 포함하는 사료첨가용 조성물 |
KR101370943B1 (ko) * | 2012-04-05 | 2014-03-12 | 씨제이제일제당 (주) | 신규 분리한 바실러스 리체니포미스 및 이를 이용한 프로바이오틱스 |
CN104411182A (zh) * | 2012-04-12 | 2015-03-11 | 杜邦营养生物科学有限公司 | 微生物菌株及其在动物中的用途 |
CN102895677B (zh) * | 2012-10-30 | 2014-03-12 | 无锡海健生物科技有限公司 | 一种新型对虾多价载体疫苗及其应用 |
CN103301409B (zh) | 2013-07-04 | 2015-01-21 | 宜春强微生物科技有限公司 | 防治虾偷死病的组合物及其制备方法 |
CN104195068A (zh) * | 2014-07-25 | 2014-12-10 | 青岛尚德生物技术有限公司 | 一种用于预防和治疗对虾早期死亡综合症的复合微生态制剂及其应用 |
CN104312961A (zh) * | 2014-10-27 | 2015-01-28 | 中国水产科学研究院黄海水产研究所 | 一种枯草芽孢杆菌菌株及其应用 |
CN104388338B (zh) * | 2014-10-27 | 2015-06-24 | 中国水产科学研究院黄海水产研究所 | 一种复合菌制剂及其应用 |
WO2016073981A1 (en) * | 2014-11-07 | 2016-05-12 | BiOWiSH Technologies, Inc. | Antibacterial compositions and methods of use |
KR101738591B1 (ko) | 2015-02-06 | 2017-05-24 | 한국해양자원연구소 주식회사 어업회사법인 | 갑각류 양식용 미생물 제재 및 이를 이용한 갑각류의 생산성 증진방법 |
CN104664164A (zh) * | 2015-03-11 | 2015-06-03 | 任芳芳 | 一种可降低南美白对虾白斑综合征病毒病害的饲料添加剂 |
US11771065B2 (en) | 2015-08-20 | 2023-10-03 | Api Holdings, Llc | Formulations and methods for promoting honeybee health |
EP3397061A1 (en) * | 2015-12-28 | 2018-11-07 | Novozymes BioAG A/S | Heat priming of bacterial spores |
CN108603166A (zh) * | 2016-02-23 | 2018-09-28 | 诺维信公司 | 用于预防虾病的直接饲喂微生物 |
KR20190082122A (ko) * | 2017-12-29 | 2019-07-09 | 씨제이제일제당 (주) | 바실러스 서브틸리스 균주를 유효성분으로 포함하는 급성 췌장염 괴사증 (ahpnd) 또는 흰반점 증후군(wss)의 예방 또는 치료용 사료 조성물 |
-
2018
- 2018-12-27 KR KR1020180171279A patent/KR20190082122A/ko not_active IP Right Cessation
- 2018-12-27 KR KR1020180171280A patent/KR102277987B1/ko active IP Right Grant
- 2018-12-28 US US16/461,348 patent/US20200315211A1/en not_active Abandoned
- 2018-12-28 BR BR112019007616-6A patent/BR112019007616B1/pt active IP Right Grant
- 2018-12-28 JP JP2019520990A patent/JP6898989B2/ja active Active
- 2018-12-28 US US16/349,838 patent/US11432566B2/en active Active
- 2018-12-28 EP EP18859983.1A patent/EP3530123A4/en active Pending
- 2018-12-28 JP JP2019521083A patent/JP6812545B2/ja active Active
- 2018-12-28 TW TW107147914A patent/TWI722358B/zh active
- 2018-12-28 BR BR112019007636-0A patent/BR112019007636B1/pt active IP Right Grant
- 2018-12-28 EP EP18859986.4A patent/EP3530124A4/en active Pending
- 2018-12-28 CN CN201880004734.3A patent/CN110602950A/zh active Pending
- 2018-12-28 CN CN201880004885.9A patent/CN110278704A/zh active Pending
- 2018-12-28 TW TW107147913A patent/TWI693894B/zh active
- 2018-12-28 AR ARP180103905A patent/AR113725A1/es unknown
- 2018-12-28 AU AU2018395021A patent/AU2018395021A1/en not_active Abandoned
- 2018-12-28 AU AU2018395016A patent/AU2018395016B2/en active Active
- 2018-12-28 AR ARP180103904A patent/AR113724A1/es unknown
-
2019
- 2019-04-16 PH PH12019500838A patent/PH12019500838A1/en unknown
- 2019-05-16 PH PH12019501100A patent/PH12019501100A1/en unknown
- 2019-05-30 CL CL2019001464A patent/CL2019001464A1/es unknown
- 2019-05-30 CL CL2019001463A patent/CL2019001463A1/es unknown
-
2020
- 2020-07-29 EC ECSENADI202044912A patent/ECSP20044912A/es unknown
- 2020-07-29 EC ECSENADI202044931A patent/ECSP20044931A/es unknown
- 2020-07-29 CO CONC2020/0009486A patent/CO2020009486A2/es unknown
- 2020-07-29 CO CONC2020/0009472A patent/CO2020009472A2/es unknown
- 2020-12-11 CL CL2020003225A patent/CL2020003225A1/es unknown
-
2021
- 2021-02-26 JP JP2021030743A patent/JP7036964B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP20044931A (es) | Una composición de pienso para la prevención o el tratamiento de la enfermedad de la necrosis hepatopancreática aguda ahpnd o el síndrome de las manchas blancas wss, que como componentes activos comprende una cepa de bacillus subtilis una cepa de bacillus pumilus y una cepa de bacillus licheniformis | |
CO2019009215A2 (es) | Sal hemi-sulfato de nucleótido para el tratamiento del virus de la hepatitis c | |
PE20171439A1 (es) | Metodos para tratar infecciones por el virus filoviridae | |
CL2016001811A1 (es) | Compuestos heterociclos derivados de 3-(azepan-1-il-sulfonil)-n-fenilbenzamida; composición farmacéutica, útiles para tratar y prevenir la infección por vhb | |
CL2018000706A1 (es) | Derivados de pirazolopirimidina como inhibidores btk para el tratamiento del cancer. | |
ECSP10010618A (es) | Análogos carba - nucleósidos para tratamiento antiviral | |
CL2016000952A1 (es) | Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2015002680A1 (es) | Composición farmaceutica que comprende un activador de ampk y un agente serotoninérgico y método para usar los mismos | |
EP2494059A4 (en) | USE OF METHYSULFONYLMETHANE (MSM) FOR MODULATION OF MICROBIAL ACTIVITY | |
CL2020000487A1 (es) | Agentes antivirales contra la hepatitis b. | |
CO2017006308A2 (es) | Derivados de glucagón | |
ECSP10010042A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119 | |
ECSP18071568A (es) | Agente microbiano de suministro directo para la prevención de una patología del camarón | |
CL2011000558A1 (es) | Formas cristalinas de un compuesto derivado de 2-tiazolil-4-quinolinil-oxi; sal de sodio del compuesto, composicion farmaceutica que comprende la sal de sodio, util para tratar una infeccion por el virus de la hepatitis c. | |
CL2017001822A1 (es) | Derivados de indol mono o disustituido como inhibidores de la replicación del virus del dengue | |
ES2380951T3 (es) | Diaril-purinas, -azapurinasy - desazapurinas como inhibidores no nucleósidos de la transcriptasa inversa para el tratamiento del VIH | |
PE20190381A1 (es) | Oligonucleotidos antisentido para modular la expresion de htra1 | |
UY32715A (es) | Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados | |
UY32720A (es) | Combinaciones farmaceuticas utiles para el tratamiento del virus de la hepatitis c (vhc), usos y metodos relacionados | |
UY32721A (es) | Composiciones farmacéuticas útiles para tratar el virus de la hepatitis c (vhc), usos y métodos relacionados | |
SV2010003694A (es) | Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de leucotrieno a4 hidrolasa | |
BR112017002629A2 (pt) | decoys de oligonucleotídeo para o tratamento de dor | |
CO6660456A2 (es) | Agente preventivo o terpéutico contra la fibrosis | |
AR082278A1 (es) | Vacunas de enterovirus para prevenir o tratar diabetes tipo 1 (iii) | |
AR062939A1 (es) | Agente para el tratamiento y/o prevencion del tizon |